Document Classification

Section Type: RESULTS

Text: Women receiving MQ had reduced risks of parasitemia (63/1, 372 [4. 6 %] in the SP group and 88/2, 737 [3. 2 %] in the MQ group ; RR, 0. 70 [95 % CI 0. 51-0. 96] ; p = 0. 03) and anemia at delivery (609/1, 380 [44. 1 %] in the SP group and 1, 110 / 2743 [40. 5 %] in the MQ group ; RR, 0. 92 [95 % CI 0. 85-0. 99] ; p = 0. 03), and reduced incidence of clinical malaria (96/551. 8 malaria episodes person/year [PYAR] in the SP group and 130/1, 103. 2 episodes PYAR in the MQ group ; RR, 0. 67 [95 % CI 0. 52-0. 88] ; p = 0. 004) and all-cause outpatient attendances during pregnancy (850/557. 8 outpatients visits PYAR in the SP group and 1, 480 / 1, 110. 1 visits PYAR in the MQ group ; RR, 0. 86 [0. 78-0. 95] ; p = 0. 003).